It's no secret that we're currently facing a widespread #Obesity crisis. As a result, there has been a surge in cutting-edge research, treatments, and technology aimed at enhancing #PopulationHealth, such as the use of GLP1s like Wegovy in medicated weight loss programmes. But while the recent advancements in #GLP1 research appear promising, we are still in the early stages of enabling individuals to take full advantage of these developments for long-term health benefits beyond a #ClinicalResearch environment. Additionally, emerging studies are beginning to shed light on how these drugs may directly impact priority health areas like #CardiovascularDisease. Next month, we'll be hosting our own webinar on this important topic featuring insights from renowned weight-loss clinician, Dr Sue Kenneally, and our Director of Product & Data, Tamar Loach. We'll delve into the current state of #MedicatedWeightLoss, highlight emerging developments, and discuss the importance of supporting consumers with actionable lifestyle advice and health-tracking tools that can drive sustainable behaviour change. We'll also be exploring the essential role of pharmacies in connecting individuals focused on #Health and #Wellness to research paradigms. 🎙️ During the webinar, you'll gain insights into: • Current and emerging weight-loss medications and treatments • Scaling research with remote diagnostics • Integrating consumer data to enhance patient engagement 📅 Webinar details • Date: Thursday, 11th July • Time: 2:00 - 3:00 PM BST Secure your spot today by registering using the link below: https://lnkd.in/dmEUSRAm #Health | #MedicatedWeightLoss | #Pharmacy | #Research | #Innovation | #Healthcare
Thriva Solutions’ Post
More Relevant Posts
-
With treatments becoming more ambitious, complex and expensive, how can healthcare stakeholders overcome prescriber inertia to improve patient outcomes? Behavioural science could be the solution. It’s been used to encourage people to follow COVID-19 guidelines, take up vaccines and make healthier lifestyle choices, and the UK’s Medical Research Council (MRC) is now advocating its use in the design of interventions such as marketing campaigns. In this article published last year in Simedics (The Journal of mHealth), Alpharmaxim’s William Hind looks into the 93 different techniques that can be combined to address barriers to change and explains how strong, evidence-based insights can overcome negative perceptions and deliver real results for patients. #BehaviouralScience #BehaviourChange #LifeSciences #Alpharmaxim #PharmaMarketing https://lnkd.in/ewwJAhZY
-
-
Knowledge Management Leader - Growth Platforms (Ecosystems & Alliances and Technology Relationships) at Deloitte | Learning & Development | DFX | Business Chemistry Certified Trainer | Storyteller
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
-
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
2025 life sciences and health care industry outlooks
-
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
2025 life sciences and health care industry outlooks
-
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
2025 life sciences and health care industry outlooks
-
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
2025 life sciences and health care industry outlooks
-
Curious what's in store for the US health care and global life sciences sectors in 2025? The latest #Deloitte outlooks reveal the key trends and innovations executives are anticipating. #Biopharma #Medtech #HealthPlans #HealthSystems
2025 life sciences and health care industry outlooks
-
Healthcare Communications | Public Affairs and Patient Advocacy | Passion Partnership Champion | ISPEP member | LGBTQ+
Respect for patient autonomy has radically transformed how society engages with science and medicine. We’ve come so far in the last 10 years. But there is so much more to be done. Here’s my #ISPEP perspective on 4 reasons why the patient voice is needed to unlock the full benefit of the pharmaceutical industry to society: https://shorturl.at/W4eQu 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗶𝘀 𝗽𝗿𝗼𝗽𝗲𝗹𝗹𝗶𝗻𝗴 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 via patient-led entrepreneurship and increased clinical trial recruitment and retention. 𝗥𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 not just because it’s so obviously the right thing to do, but because increased diversity in clinical research helps combat health inequalities. 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗮𝗻𝗱 𝗽𝗼𝗹𝗶𝗰𝘆 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗶𝗻𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝗿𝗲 𝗯𝗲𝘁𝘁𝗲𝗿 than those without, helping to keep healthcare relevant to real-world needs. 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗵𝗲𝗹𝗽𝘀 𝗯𝗼𝗼𝘀𝘁 𝗵𝗲𝗮𝗹𝘁𝗵 𝗹𝗶𝘁𝗲𝗿𝗮𝗰𝘆 and combat harmful online myths. I'm excited to be part of the positive disruption patient engagement can bring for Pharma, medicine, and the politics of health. But we can only realise the potential of this if experts in science and lived experience are given the same value – and power. ISPEP is fantastic organisation set up to provide resources, facilitate community connections, and tackle the tough challenges to unlock the full value of patient engagement for society. If you’re new to the field, or want to sharpen your skills, I recommend you join and follow ISPEP. You’ll be warmly welcomed by a varied collection of people from different backgrounds in a non-competitive, non-hierarchical, and genuinely collaborative environment! Contact Emma Sutcliffe if you’d like to join! #patientengagement #healthcare #innovation #clinicaltrials #healthliteracy
What are the benefits of patient engagement for society?
ispephub.org
-
Director, National Accounts - Health System Engagement Strategy | HBA Phoenix Chapter Programming Committee Member
- Embrace the evolving IDN landscape to maximize market effectiveness. - Explore how Value-Based Care shapes specific health system strategies. - Adapt your expertise to meet current IDN challenges. - Develop tailored account plans for effective engagement. - Gain insights into IDNs' pivotal role and unique collaboration approaches in the pharma sector. Reach out to us at Darwin Research Group to learn more! 🌐 #HealthcareMarketing #PharmaPartnerships #AccountPlanning #StrategicSelling #ValueBasedCare
-
At Tiga Healthcare Technologies, we constantly build and update healthcare IT solutions that drive actual differences for populations. Our Population Health Management products give healthcare authorities chances to ensure the healthcare systems’ effectiveness. As you are well aware, healthcare authorities confront intricate challenges daily and the exploitation of clear and comprehensive data is crucial for making more informed decisions. Accordingly, data-driven insights are the real power of our Population Health Management products. This product family includes Health Analytics and Reporting, which provides customizable data analyses for improved population health and compliance; Chronic Disease Management, which provides treatment guidelines for personalized care and Predis, an early warning system for anomaly detection in healthcare delivery and the pharmaceutical supply chain. The future of healthcare is all about using data better and we're using it to create patient-centric solutions that will improve health outcomes for the population. Let's shape the future together, as always! #Tiga #HealthcareIT #PharmaIT #PopulationHealthManagement
